Three in five liver cancer cases are due to preventable risk factors
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer c1
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer c1
The European Association for the Study of the Liver (EASL) has published an update of its guidelines for the management of hepatocellular carcinoma (1
Last week, an event was held in Barcelona by the Association Against Cancer (AECC) to present the Research Grants 2023 that will be carried out in th1
Researchers from the Hospital Clínic-IDIBAPS have participated in the preparation of the new guidelines on intrahepatic cholangiocarcinoma, the secon1
The mortality rate during the first month of infection for patients with advanced-stage hepatocellular carcinoma rose to 20.7%.
Interview with Dr Maria Reig, head of the Hepatic Oncology Unit